Suppression of replicative senescence by rapamycin in rodent embryonic cells

References

• Shay JW, Wright WE. Hayflick, his limit, and cellular ageing. Nat Rev Mol Cell Biol 2000; 1:72 - 6; http://dx.doi.org/10.1038/35036093; PMID: 11413492
   PubMed Web of Science ®Google Scholar
• Campisi J, Kim SH, Lim CS, Rubio M. Cellular senescence, cancer and aging: the telomere connection. Exp Gerontol 2001; 36:1619 - 37; http://dx.doi.org/10.1016/S0531-5565(01)00160-7; PMID: 11672984
   PubMed Web of Science ®Google Scholar
• Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279:349 - 52; http://dx.doi.org/10.1126/science.279.5349.349; PMID: 9454332
   PubMed Web of Science ®Google Scholar
• Russo I, Silver AR, Cuthbert AP, Griffin DK, Trott DA, Newbold RF. A telomere-independent senescence mechanism is the sole barrier to Syrian hamster cell immortalization. Oncogene 1998; 17:3417 - 26; http://dx.doi.org/10.1038/sj.onc.1202261; PMID: 10030665
   PubMed Web of Science ®Google Scholar
• Itahana K, Campisi J, Dimri GP. Mechanisms of cellular senescence in human and mouse cells. Biogerontology 2004; 5:1 - 10; http://dx.doi.org/10.1023/B:BGEN.0000017682.96395.10; PMID: 15138376
   PubMed Web of Science ®Google Scholar
• Serrano M, Blasco MA. Putting the stress on senescence. Curr Opin Cell Biol 2001; 13:748 - 53; http://dx.doi.org/10.1016/S0955-0674(00)00278-7; PMID: 11698192
   PubMed Web of Science ®Google Scholar
• Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88:593 - 602; http://dx.doi.org/10.1016/S0092-8674(00)81902-9; PMID: 9054499
   PubMed Web of Science ®Google Scholar
• Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M, Lowe SW. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 1998; 12:3008 - 19; http://dx.doi.org/10.1101/gad.12.19.3008; PMID: 9765203
   PubMed Web of Science ®Google Scholar
• Lloyd AC, Obermüller F, Staddon S, Barth CF, McMahon M, Land H. Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev 1997; 11:663 - 77; http://dx.doi.org/10.1101/gad.11.5.663; PMID: 9119230
   PubMed Web of Science ®Google Scholar
• Sewing A, Wiseman B, Lloyd AC, Land H. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol Cell Biol 1997; 17:5588 - 97; PMID: 9271434
   PubMed Web of Science ®Google Scholar
• Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol 1997; 17:5598 - 611; PMID: 9271435
   PubMed Web of Science ®Google Scholar
• Zhu JY, Woods D, McMahon M, Bishop JM. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev 1998; 12:2997 - 3007; http://dx.doi.org/10.1101/gad.12.19.2997; PMID: 9765202
   PubMed Web of Science ®Google Scholar
• Kerkhoff E, Rapp UR. High-intensity Raf signals convert mitotic cell cycling into cellular growth. Cancer Res 1998; 58:1636 - 40; PMID: 9563474
   PubMed Web of Science ®Google Scholar
• Kortum RL, Johnson HJ, Costanzo DL, Volle DJ, Razidlo GL, Fusello AM, et al. The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence. Mol Cell Biol 2006; 26:2202 - 14; http://dx.doi.org/10.1128/MCB.26.6.2202-2214.2006; PMID: 16507997
   PubMed Web of Science ®Google Scholar
• Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, Bajraszewski N, et al. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 2003; 112:1223 - 33; PMID: 14561707
   PubMed Web of Science ®Google Scholar
• Zhang H, Bajraszewski N, Wu E, Wang H, Moseman AP, Dabora SL, et al. PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR. J Clin Invest 2007; 117:730 - 8; http://dx.doi.org/10.1172/JCI28984; PMID: 17290308
   PubMed Web of Science ®Google Scholar
• Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004; 18:1926 - 45; http://dx.doi.org/10.1101/gad.1212704; PMID: 15314020
   PubMed Web of Science ®Google Scholar
• Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 2005; 37:19 - 24; http://dx.doi.org/10.1038/ng1494; PMID: 15624019
   PubMed Web of Science ®Google Scholar
• Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006; 124:471 - 84; http://dx.doi.org/10.1016/j.cell.2006.01.016; PMID: 16469695
   PubMed Web of Science ®Google Scholar
• Dann SG, Selvaraj A, Thomas G. mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med 2007; 13:252 - 9; http://dx.doi.org/10.1016/j.molmed.2007.04.002; PMID: 17452018
   PubMed Web of Science ®Google Scholar
• Dazert E, Hall MN. mTOR signaling in disease. Curr Opin Cell Biol 2011; 23:744 - 55; http://dx.doi.org/10.1016/j.ceb.2011.09.003; PMID: 21963299
   PubMed Web of Science ®Google Scholar
• Conn CS, Qian SB. mTOR signaling in protein homeostasis: less is more?. Cell Cycle 2011; 10:1940 - 7; http://dx.doi.org/10.4161/cc.10.12.15858; PMID: 21555915
   PubMed Web of Science ®Google Scholar
• Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 2009; 10:307 - 18; http://dx.doi.org/10.1038/nrm2672; PMID: 19339977
   PubMed Web of Science ®Google Scholar
• Demidenko ZN, Blagosklonny MV. Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle 2008; 7:3355 - 61; http://dx.doi.org/10.4161/cc.7.21.6919; PMID: 18948731
   PubMed Web of Science ®Google Scholar
• Demidenko ZN, Zubova SG, Bukreeva EI, Pospelov VA, Pospelova TV, Blagosklonny MV. Rapamycin decelerates cellular senescence. Cell Cycle 2009; 8:1888 - 95; http://dx.doi.org/10.4161/cc.8.12.8606; PMID: 19471117
   PubMed Web of Science ®Google Scholar
• Demidenko ZN, Shtutman M, Blagosklonny MV. Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence. Cell Cycle 2009; 8:1896 - 900; http://dx.doi.org/10.4161/cc.8.12.8809; PMID: 19478560
   PubMed Web of Science ®Google Scholar
• Demidenko ZN, Blagosklonny MV. At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence. Cell Cycle 2009; 8:1901 - 4; http://dx.doi.org/10.4161/cc.8.12.8810; PMID: 19471118
   PubMed Web of Science ®Google Scholar
• Demidenko ZN, Blagosklonny MV. Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential. Aging 2009; 1:1008 - 16; PMID: 20157583
   PubMedGoogle Scholar
• Pospelova TV, Demidenko ZN, Bukreeva EI, Pospelov VA, Gudkov AV, Blagosklonny MV. Pseudo-DNA damage response in senescent cells. Cell Cycle 2009; 8:4112 - 8; http://dx.doi.org/10.4161/cc.8.24.10215; PMID: 19946210
   PubMed Web of Science ®Google Scholar
• Romanov VS, Abramova MV, Svetlikova SB, Bykova TV, Zubova SG, Aksenov ND, et al. p21(Waf1) is required for cellular senescence but not for cell cycle arrest induced by the HDAC inhibitor sodium butyrate. Cell Cycle 2010; 9:3945 - 55; http://dx.doi.org/10.4161/cc.9.19.13160; PMID: 20935470
   PubMed Web of Science ®Google Scholar
• Demidenko ZN, Korotchkina LG, Gudkov AV, Blagosklonny MV. Paradoxical suppression of cellular senescence by p53. Proc Natl Acad Sci USA 2010; 107:9660 - 4; http://dx.doi.org/10.1073/pnas.1002298107; PMID: 20457898
   PubMed Web of Science ®Google Scholar
• Korotchkina LG, Leontieva OV, Bukreeva EI, Demidenko ZN, Gudkov AV, Blagosklonny MV. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging 2010; 2:344 - 52; PMID: 20606252
   PubMedGoogle Scholar
• Leontieva OV, Blagosklonny MV. DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence. Aging 2010; 2:924 - 35; PMID: 21212465
   PubMedGoogle Scholar
• Leontieva OV, Gudkov AV, Blagosklonny MV. Weak p53 permits senescence during cell cycle arrest. Cell Cycle 2010; 9:4323 - 7; http://dx.doi.org/10.4161/cc.9.21.13584; PMID: 21051933
   PubMed Web of Science ®Google Scholar
• Leontieva OV, Demidenko ZN, Gudkov AV, Blagosklonny MV. Elimination of proliferating cells unmasks the shift from senescence to quiescence caused by rapamycin. PLoS ONE 2011; 6:e26126; http://dx.doi.org/10.1371/journal.pone.0026126; PMID: 22022534
   PubMedGoogle Scholar
• Blagosklonny MV. Aging, stem cells, and mammalian target of rapamycin: a prospect of pharmacologic rejuvenation of aging stem cells. Rejuvenation Res 2008; 11:801 - 8; http://dx.doi.org/10.1089/rej.2008.0722; PMID: 18729812
   PubMed Web of Science ®Google Scholar
• Chen C, Liu Y, Liu Y, Zheng P. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci Signal 2009; 2:ra75; http://dx.doi.org/10.1126/scisignal.2000559; PMID: 19934433
   PubMed Web of Science ®Google Scholar
• Gan B, DePinho RA. mTORC1 signaling governs hematopoietic stem cell quiescence. Cell Cycle 2009; 8:1003 - 6; http://dx.doi.org/10.4161/cc.8.7.8045; PMID: 19270523
   PubMed Web of Science ®Google Scholar
• Castilho RM, Squarize CH, Chodosh LA, Williams BO, Gutkind JS. mTOR mediates Wnt-induced epidermal stem cell exhaustion and aging. Cell Stem Cell 2009; 5:279 - 89; http://dx.doi.org/10.1016/j.stem.2009.06.017; PMID: 19733540
   PubMed Web of Science ®Google Scholar
• Stipp D. A new path to longevity. Sci Am 2012; 306:32 - 9; http://dx.doi.org/10.1038/scientificamerican0112-32; PMID: 22279832
   PubMed Web of Science ®Google Scholar
• Vellai T, Takacs-Vellai K, Zhang Y, Kovacs AL, Orosz L, Müller F. Genetics: influence of TOR kinase on lifespan in C. elegans. Nature 2003; 426:620; http://dx.doi.org/10.1038/426620a; PMID: 14668850
   PubMed Web of Science ®Google Scholar
• Powers RW 3rd, Kaeberlein M, Caldwell SD, Kennedy BK, Fields S. Extension of chronological lifespan in yeast by decreased TOR pathway signaling. Genes Dev 2006; 20:174 - 84; http://dx.doi.org/10.1101/gad.1381406; PMID: 16418483
   PubMed Web of Science ®Google Scholar
• Kaeberlein M, Powers RW 3rd, Steffen KK, Westman EA, Hu D, Dang N, et al. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science 2005; 310:1193 - 6; http://dx.doi.org/10.1126/science.1115535; PMID: 16293764
   PubMed Web of Science ®Google Scholar
• Jia K, Chen D, Riddle DL. The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span. Development 2004; 131:3897 - 906; http://dx.doi.org/10.1242/dev.01255; PMID: 15253933
   PubMed Web of Science ®Google Scholar
• Kapahi P, Zid BM, Harper T, Koslover D, Sapin V, Benzer S. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr Biol 2004; 14:885 - 90; http://dx.doi.org/10.1016/j.cub.2004.03.059; PMID: 15186745
   PubMed Web of Science ®Google Scholar
• Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009; 460:392 - 5; PMID: 19587680
   PubMed Web of Science ®Google Scholar
• Selman C, Tullet JM, Wieser D, Irvine E, Lingard SJ, Choudhury AI, et al. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 2009; 326:140 - 4; http://dx.doi.org/10.1126/science.1177221; PMID: 19797661
   PubMed Web of Science ®Google Scholar
• Moskalev AA, Shaposhnikov MV. Pharmacological inhibition of phosphoinositide 3 and TOR kinases improves survival of Drosophila melanogaster. Rejuvenation Res 2010; 13:246 - 7; http://dx.doi.org/10.1089/rej.2009.0903; PMID: 20017609
   PubMed Web of Science ®Google Scholar
• Bjedov I, Toivonen JM, Kerr F, Slack C, Jacobson J, Foley A, et al. Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab 2010; 11:35 - 46; http://dx.doi.org/10.1016/j.cmet.2009.11.010; PMID: 20074526
   PubMed Web of Science ®Google Scholar
• Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 2011; 66:191 - 201; http://dx.doi.org/10.1093/gerona/glq178; PMID: 20974732
   PubMed Web of Science ®Google Scholar
• Anisimov VN, Zabezhinski MA, Popovich IG, Piskunova TS, Semenchenko AV, Tyndyk ML, et al. Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle 2011; 10:4230 - 6; http://dx.doi.org/10.4161/cc.10.24.18486; PMID: 22107964
   PubMed Web of Science ®Google Scholar
• Bonawitz ND, Chatenay-Lapointe M, Pan Y, Shadel GS. Reduced TOR signaling extends chronological life span via increased respiration and upregulation of mitochondrial gene expression. Cell Metab 2007; 5:265 - 77; http://dx.doi.org/10.1016/j.cmet.2007.02.009; PMID: 17403371
   PubMed Web of Science ®Google Scholar
• Alvers AL, Wood MS, Hu D, Kaywell AC, Dunn WA Jr., Aris JP. Autophagy is required for extension of yeast chronological life span by rapamycin. Autophagy 2009; 5:847 - 9; PMID: 19458476
   PubMed Web of Science ®Google Scholar
• Pan Y, Shadel GS. Extension of chronological life span by reduced TOR signaling requires down-regulation of Sch9p and involves increased mitochondrial OXPHOS complex density. Aging 2009; 1:131 - 45; PMID: 20157595
   PubMedGoogle Scholar
• Pan Y, Schroeder EA, Ocampo A, Barrientos A, Shadel GS. Regulation of yeast chronological life span by TORC1 via adaptive mitochondrial ROS signaling. Cell Metab 2011; 13:668 - 78; http://dx.doi.org/10.1016/j.cmet.2011.03.018; PMID: 21641548
   PubMed Web of Science ®Google Scholar
• Leontieva OV, Blagosklonny MV. Yeast-like chronological senescence in mammalian cells: phenomenon, mechanism and pharmacological suppression. Aging 2011; 3:1078 - 91; PMID: 22156391
   PubMedGoogle Scholar
• Fabrizio P, Wei M. Conserved role of medium acidification in chronological senescence of yeast and mammalian cells. Aging 2011; 3:1127 - 9; PMID: 22184281
   PubMedGoogle Scholar
• Kaeberlein M, Kennedy BK. A new chronological survival assay in mammalian cell culture. Cell Cycle 2012; 11:201 - 2; http://dx.doi.org/10.4161/cc.11.2.18959; PMID: 22214665
   PubMed Web of Science ®Google Scholar
• Kaeberlein M, Hu D, Kerr EO, Tsuchiya M, Westman EA, Dang N, et al. Increased life span due to calorie restriction in respiratory-deficient yeast. PLoS Genet 2005; 1:e69; http://dx.doi.org/10.1371/journal.pgen.0010069; PMID: 16311627
   PubMed Web of Science ®Google Scholar
• Urban J, Soulard A, Huber A, Lippman S, Mukhopadhyay D, Deloche O, et al. Sch9 is a major target of TORC1 in Saccharomyces cerevisiae. Mol Cell 2007; 26:663 - 74; http://dx.doi.org/10.1016/j.molcel.2007.04.020; PMID: 17560372
   PubMed Web of Science ®Google Scholar
• Steffen KK, MacKay VL, Kerr EO, Tsuchiya M, Hu D, Fox LA, et al. Yeast life span extension by depletion of 60s ribosomal subunits is mediated by Gcn4. Cell 2008; 133:292 - 302; http://dx.doi.org/10.1016/j.cell.2008.02.037; PMID: 18423200
   PubMed Web of Science ®Google Scholar
• Steinkraus KA, Kaeberlein M, Kennedy BK. Replicative aging in yeast: the means to the end. Annu Rev Cell Dev Biol 2008; 24:29 - 54; http://dx.doi.org/10.1146/annurev.cellbio.23.090506.123509; PMID: 18616424
   PubMed Web of Science ®Google Scholar
• Ha CW, Huh WK. The implication of Sir2 in replicative aging and senescence in Saccharomyces cerevisiae. Aging 2011; 3:319 - 24; PMID: 21415463
   PubMedGoogle Scholar
• Satyanarayana A, Greenberg RA, Schaetzlein S, Buer J, Masutomi K, Hahn WC, et al. Mitogen stimulation cooperates with telomere shortening to activate DNA damage responses and senescence signaling. Mol Cell Biol 2004; 24:5459 - 74; http://dx.doi.org/10.1128/MCB.24.12.5459-5474.2004; PMID: 15169907
   PubMed Web of Science ®Google Scholar
• Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S, Campisi J. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol 2003; 5:741 - 7; http://dx.doi.org/10.1038/ncb1024; PMID: 12855956
   PubMed Web of Science ®Google Scholar
• Sofer A, Lei K, Johannessen CM, Ellisen LW. Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol Cell Biol 2005; 25:5834 - 45; http://dx.doi.org/10.1128/MCB.25.14.5834-5845.2005; PMID: 15988001
   PubMed Web of Science ®Google Scholar
• Arsham AM, Howell JJ, Simon MC. A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J Biol Chem 2003; 278:29655 - 60; http://dx.doi.org/10.1074/jbc.M212770200; PMID: 12777372
   PubMed Web of Science ®Google Scholar
• Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, Hafen E, et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 2004; 18:2893 - 904; http://dx.doi.org/10.1101/gad.1256804; PMID: 15545625
   PubMed Web of Science ®Google Scholar
• Connolly E, Braunstein S, Formenti S, Schneider RJ. Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells. Mol Cell Biol 2006; 26:3955 - 65; http://dx.doi.org/10.1128/MCB.26.10.3955-3965.2006; PMID: 16648488
   PubMed Web of Science ®Google Scholar
• Liu L, Cash TP, Jones RG, Keith B, Thompson CB, Simon MC. Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol Cell 2006; 21:521 - 31; http://dx.doi.org/10.1016/j.molcel.2006.01.010; PMID: 16483933
   PubMed Web of Science ®Google Scholar
• DeYoung MP, Horak P, Sofer A, Sgroi D, Ellisen LW. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev 2008; 22:239 - 51; http://dx.doi.org/10.1101/gad.1617608; PMID: 18198340
   PubMed Web of Science ®Google Scholar
• Cam H, Easton JB, High A, Houghton PJ. mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1α. Mol Cell 2010; 40:509 - 20; http://dx.doi.org/10.1016/j.molcel.2010.10.030; PMID: 21095582
   PubMed Web of Science ®Google Scholar
• Wolff NC, Vega-Rubin-de-Celis S, Xie XJ, Castrillon DH, Kabbani W, Brugarolas J. Cell-type-dependent regulation of mTORC1 by REDD1 and the tumor suppressors TSC1/TSC2 and LKB1 in response to hypoxia. Mol Cell Biol 2011; 31:1870 - 84; http://dx.doi.org/10.1128/MCB.01393-10; PMID: 21383064
   PubMed Web of Science ®Google Scholar
• Kolesnichenko M, Hong L, Liao R, Vogt PK, Sun P. Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence. [this issue.] Cell Cycle 2012; 11:11 - 2; PMID: 22157090
   PubMed Web of Science ®Google Scholar